iShares U.S. Healthcare ETF (NYSEARCA:IYH) Hits New 52-Week High – Time to Buy?

iShares U.S. Healthcare ETF (NYSEARCA:IYH) reached a new 52-week high on Wednesday . The stock traded as high as $67.15 and last traded at $67.4190, with a volume of 35056 shares trading hands. The stock had previously closed at $66.58.

iShares U.S. Healthcare ETF Trading Down 1.0%

The stock has a market capitalization of $3.64 billion, a PE ratio of 21.05 and a beta of 0.65. The stock has a 50 day moving average price of $64.59 and a 200-day moving average price of $60.16.

Institutional Investors Weigh In On iShares U.S. Healthcare ETF

A number of large investors have recently made changes to their positions in the company. RMG Wealth Management LLC bought a new position in shares of iShares U.S. Healthcare ETF in the 2nd quarter worth approximately $28,000. Financial Perspectives Inc bought a new stake in iShares U.S. Healthcare ETF during the second quarter valued at approximately $30,000. Flaharty Asset Management LLC purchased a new stake in iShares U.S. Healthcare ETF during the first quarter valued at approximately $37,000. SJS Investment Consulting Inc. bought a new position in iShares U.S. Healthcare ETF in the third quarter worth approximately $36,000. Finally, Assetmark Inc. raised its position in iShares U.S. Healthcare ETF by 98.4% in the second quarter. Assetmark Inc. now owns 734 shares of the company’s stock worth $41,000 after acquiring an additional 364 shares during the period.

About iShares U.S. Healthcare ETF

iShares U.S. Healthcare ETF (the Fund), formerly iShares Dow Jones U.S. Healthcare Sector Index Fund (the Fund) is a non-diversified exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Health Care Index (the Index). The Index measures the performance of the healthcare sector of the United States equity market, and includes companies in the industry groups, such as healthcare equipment and services, pharmaceuticals and biotechnology.